Cureus | A Patient of Multiple Myeloma with Absent M-spike on Serum Protein Electrophoresis and Elevated Serum-Free Light Chains: A Case Report and Literature Review | Article
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
Medicina | Free Full-Text | The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
Discrepancy in serum free light chain analysis compared with serum... | Download Scientific Diagram
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
Correspondence data for kappa and lambda free light chain analysis | Download Table
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma - Abbi - 2016 - British Journal of Haematology - Wiley Online Library
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
Table 4 from Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine. | Semantic Scholar
Viruses | Free Full-Text | Urine and Free Immunoglobulin Light Chains as Analytes for Serodiagnosis of Hantavirus Infection
Following & Understanding Your Free Light Chain Test Results - YouTube
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - ScienceDirect
For Myeloma Diagnosis, Urine Tests May Be Better Than Serum, Study Finds